Why Has Cel-Sci Quietly Amended Some Previously Filed Paperwork? [View article]
Why has Celsci made an amendment?
Why does M.E. Garza continue to put out press releases and articles on Celsci? How much are they paying him? How much stock does he have to get rid of?
A Biotech Triple Play: Dendreon, BioCryst and Arena [View article]
Somehow my comment disappeared so maybe i need to be a little softer.
You made two MAJOR gaffes in your Biocryst analysis. One, Tamiflu is ORAL not injected. As a pill it's going to be dramatically cheaper to make, distribute and administer, plus it's actually effective unlike peramivir.
Two, Biocryst has a market valuation of $140M not $1.4B. This is a 10X difference, so your $4B target is 29X. This is a serious mistake on your part.
Peramivir has been shown in trial after trial that it doesn't work or barely has any effect at all. Stockpiling an ineffective drug, sure i guess the US government does dumber things. But driving Biocryst stock to a 29-fold gain, i don't think so.
Why Has Cel-Sci Quietly Amended Some Previously Filed Paperwork? [View article]
Why does M.E. Garza continue to put out press releases and articles on Celsci? How much are they paying him? How much stock does he have to get rid of?
A Biotech Triple Play: Dendreon, BioCryst and Arena [View article]
So are you suggesting your price target for Biocryst is now 400M and not 4B?
A Biotech Triple Play: Dendreon, BioCryst and Arena [View article]
You made two MAJOR gaffes in your Biocryst analysis.
One, Tamiflu is ORAL not injected. As a pill it's going to be dramatically cheaper to make, distribute and administer, plus it's actually effective unlike peramivir.
Two, Biocryst has a market valuation of $140M not $1.4B. This is a 10X difference, so your $4B target is 29X. This is a serious mistake on your part.
Peramivir has been shown in trial after trial that it doesn't work or barely has any effect at all. Stockpiling an ineffective drug, sure i guess the US government does dumber things. But driving Biocryst stock to a 29-fold gain, i don't think so.